News Carfilzomib gives survival benefits to patients with relapsed multiple myelomaPublished: 18 December 2014
Opinion The European Medicines Agency still has a way to go towards clinical trial transparencyPublished: 18 December 2014
News Crizotinib offers survival benefits over standard chemotherapy in patients with ALK-positive lung cancerPublished: 18 December 2014